Tech Selloff Deepens as Geopolitical Tensions Weigh on Markets

U.S. equities closed lower across most indices Tuesday as technology weakness and geopolitical headwinds overwhelmed scattered strength in healthcare and energy stocks.

The S&P 500 fell 0.49% to $747.62, while the Nasdaq 100 suffered a steeper 1.85% decline to $709.43. The broader Russell 2000 lost 0.90%, underperforming large-cap indexes. Only the Dow Jones held relatively steady, down just 0.31% at $528.43, reflecting defensive positioning.

Sector Rotation: From Growth to Stability

Technology led declines with a 2.73% sector drop, extending recent momentum losses. Basic Materials fell 2.81% and Industrials tumbled 2.57%, suggesting investors rotated away from cyclical bets amid mixed economic signals. Energy bucked the trend, gaining 1.18% after the Treasury revoked its waiver for Iranian oil sales, triggering vessel attacks in the Strait of Hormuz and pushing crude prices higher.

The tech weakness presented a clear tale of two narratives. NVDA demonstrated notable resilience, bucking a 5% selloff in the VanEck Semiconductor ETF—a signal that markets are betting on the chipmaker's isolated strength and new CPU supply deal with Perplexity as it expands beyond GPUs. Meanwhile, SPCX plummeted below its Nasdaq-100 debut price as broader sector malaise dragged the rocket maker lower.

Biotech Bonanza: Explosive One-Day Moves

The day's most striking moves came from small-cap healthcare names. CRNX surged 98.7% to $83.53 on an undisclosed catalyst—likely a clinical trial success or regulatory approval. AGIO followed with a 17.7% jump, while VKTX, TRVI, and BCRX each gained between 8.1% and 8.8%. Healthcare as a sector gained 0.73%, making it one of few bright spots.

These moves signal retail appetite for speculative biotech bets, though investors should note the lack of disclosed catalysts behind several gainers—a red flag for sustainability.

Earnings Point to Mixed Momentum

BNED delivered an impressive 166% EPS beat, though revenue slightly missed expectations at –9%. EXYN posted a 19% EPS beat with a stronger 76% revenue beat, suggesting operational efficiency gains outpacing top-line growth. Neither catalyst proved strong enough to reverse broader market sentiment.

What This Means

Today's action reflects a market in transition: growth and cyclical trades are losing favor as geopolitical risk (Iranian oil escalation) and AI volatility (Samsung earnings disappointment) create headwinds. The Nasdaq 100's 1.85% decline versus the Dow's 0.31% shows investors seeking safety in dividend-paying, non-tech names.

The biotech explosions appear isolated—a retail-driven speculative event rather than a sector-wide signal. Energy's gains on Strait of Hormuz tensions could persist if geopolitical risk remains elevated.

Looking Ahead

Watch whether tech weakness deepens or stabilizes tomorrow, particularly around semiconductor names beyond NVDA. Additional earnings and Fed commentary could shift sentiment. Energy stocks warrant monitoring if shipping disruptions escalate, while defensives like Consumer Defensive (+0.48%) may continue attracting safe-haven flows.

Multiple bullish signals are converging in MU, TSM, and MKC, suggesting pockets of opportunity remain for disciplined buyers.